Delivery Order SPE2DR25D3015-SPE2DR26F4FJ6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,357.37 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on December 5, 2025, with completion scheduled for December 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,973.52 to AmerisourceBergen Drug Corp for the supply of Arimidex (Anastrozole) 1 mg tablets in quantities of 30 on December 23, 2025, with completion scheduled for December 24, 2025. This firm fixed price delivery order represents a non-competitive procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999 ceiling value and extends...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in a quantity of 30 units, valued at $3,974.03. The contract, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,789.34 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on November 10, 2025, with completion scheduled for November 12, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $3,074.40 for 30 tablets of Arimidex 1 mg, with performance in Conshohocken, Pennsylvania. This competitive, non-set-aside contract reflects firm fixed pricing and is scheduled for completion on November 13, 2025. The award represents a single delivery order executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Arimidex (1 mg tablets, 30-count packages) valued at $13,374.06 under a firm fixed price contract. The award, issued on December 23, 2025, with an ultimate completion date of December 24, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and...
- The Defense Logistics Agency awarded a $9,392.18 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Arimidex 1 mg tablets (30-count packages). This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of December 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,389.99 on December 8, 2025, for the supply of Arimidex 1 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract is scheduled for completion by December 9, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the contractor's ability to compete in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count) with a ceiling value of $8,162.69. This firm fixed price, non-set-aside contract was awarded on December 23, 2025, with an ultimate completion date of December 24, 2025. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Arimidex 1 mg tablets (30-count packages) with a ceiling value of $44,205.78. This firm fixed-price delivery order, with an ultimate completion date of July 15, 2025, represents a non-set-aside competitive award and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D3015Indefinite Delivery Contract
- SPE2DR25D3015-SPE2DR26F4FJ6Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,648.43 on December 10, 2025, for the supply of Arimidex 1 mg tablets (30-count packages). This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by December 11, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains extensive federal procurement relationships with the Defense Logistics Agency and serves critical medical supply chain needs for the Department of Defense, Defense Health Agency, and other federal healthcare systems. The company's portfolio includes specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Arimidex, an aromatase inhibitor used in cancer treatment, reflects the contractor's role in providing oncology and other critical pharmaceuticals to military and veteran healthcare programs through competitive federal contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 12/9/25 |